SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
To evaluate the efficacy and safety of SRT combined with anlotinib in the treatment of limited brain metastases from non-small cell lung cancer.
Epistemonikos ID: 4882b6903d8500f35a01f49fc200908402a950c4
First added on: Jul 01, 2024